SeenewsSeenews
Search
Seenews
AlertsSeenewsSeenews
Searchclose
TOPICS
arrow
COUNTRIES
arrow
INDUSTRY
arrow
Economy
arrow
Browse Economy
Mix and match your focus countries with our advanced search
Investments
arrow
Browse Investments
Mix and match your focus countries with our advanced search
Deals
arrow
Browse Deals
Mix and match your focus countries with our advanced search
Tech
arrow
Browse Tech
Mix and match your focus countries with our advanced search
Green
arrow
Browse Green
Mix and match your focus countries with our advanced search
0/5
You have 5 free articles left this month
You have 0/5 free articles
Sign up to get 5 more free articles this month
SIGN UP
arrow
LOGIN
arrow

Slovenia's Salus extends validity of bid for 75% stake in Farmadent

Nov 18, 2022, 3:55:01 PMArticle by Radomir Ralev
share
November 18 (SeeNews) - Slovenian pharmaceutical products wholesaler Salus [LJE:SALR] has extended the validity of its binding offer for the purchase of 75% of the equity capital of local sector player Farmadent to December 15, Salus said on Friday.

Slovenia's Salus extends validity of bid for 75% stake in Farmadent
Author: Salus. License: All rights reserved.

Negotiations are still ongoing and the validity of the binding offer has been extended until December 15, Salus said in a filing with the Ljubljana Stock Exchange.

Salus submitted a binding bid for the purchase of the stake in Farmadent on September 24 and set October 19 as a deadline for the validity of its offer but later postponed it to November 3 and then to November 18.

The bid includes an option for the purchase of the remaining 25% stake in Farmadent, or alternatively the company's entire capital.

The potential acquisition of Farmadent is in line with Salus' development strategy, which envisages the expansion of activities in regions where the company is not yet present.

Your complete guide to the emerging economies of Southeast Europe. From latest news to bespoke research – the big picture at the tip of your fingers.